Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1995 Nov;69(11):7072–7086. doi: 10.1128/jvi.69.11.7072-7086.1995

Characterization of ts 16, a temperature-sensitive mutant of vaccinia virus.

M Ericsson 1, S Cudmore 1, S Shuman 1, R C Condit 1, G Griffiths 1, J K Locker 1
PMCID: PMC189627  PMID: 7474127

Abstract

We have characterized a temperature-sensitive mutant of vaccinia virus, ts16, originally isolated by Condit et al. (Virology 128:429-443, 1983), at the permissive and nonpermissive temperatures. In a previous study by Kane and Shuman (J. Virol 67:2689-2698, 1993), the mutation of ts16 was mapped to the I7 gene, encoding a 47-kDa protein that shows partial homology to the type II topoisomerase of Saccharomyces cerevisiae. The present study extends previous electron microscopy analysis, showing that in BSC40 cells infected with ts16 at the restrictive temperature (40 degrees C), the assembly was arrested at a stage between the spherical immature virus and the intracellular mature virus (IMV). In thawed cryosections, a number of the major proteins normally found in the IMV were subsequently localized to these mutant particles. By using sucrose density gradients, the ts16 particles were purified from cells infected at the permissive and nonpermissive temperatures. These were analyzed by immunogold labelling and negative-staining electron microscopy, and their protein composition was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. While the ts16 virus particles made at the permissive temperature appeared to have a protein pattern identical to that of wild-type IMV, in the mutant particles the three core proteins, p4a, p4b, and 28K, were not proteolytically processed. Consistent with previous data the sucrose-purified particles could be labelled with [3H]thymidine. In addition, anti-DNA labelling on thawed cryosections suggested that most of the mutant particles had taken up DNA. On thawed cryosections of cells infected at the permissive temperature, antibodies to I7 labelled the virus factories, the immature viruses, and the IMVs, while under restrictive conditions these structures were labelled much less, if at all. Surprisingly, however, by Western blotting (immunoblotting) the I7 protein was present in similar amounts in the defective particles and in the IMVs isolated at the permissive temperature. Finally, our data suggest that at the nonpermissive temperature the assembly of ts16 is irreversibly arrested in a stage at which the DNA is in the process of entering but before the particle has completely sealed, as monitored by protease experiments.

Full Text

The Full Text of this article is available as a PDF (3.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldick C. J., Jr, Moss B. Resistance of vaccinia virus to rifampicin conferred by a single nucleotide substitution near the predicted NH2 terminus of a gene encoding an Mr 62,000 polypeptide. Virology. 1987 Jan;156(1):138–145. doi: 10.1016/0042-6822(87)90444-2. [DOI] [PubMed] [Google Scholar]
  2. CAIRNS J. The initiation of vaccinia infection. Virology. 1960 Jul;11:603–623. doi: 10.1016/0042-6822(60)90103-3. [DOI] [PubMed] [Google Scholar]
  3. Condit R. C., Motyczka A. Isolation and preliminary characterization of temperature-sensitive mutants of vaccinia virus. Virology. 1981 Aug;113(1):224–241. doi: 10.1016/0042-6822(81)90150-1. [DOI] [PubMed] [Google Scholar]
  4. Condit R. C., Motyczka A., Spizz G. Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus. Virology. 1983 Jul 30;128(2):429–443. doi: 10.1016/0042-6822(83)90268-4. [DOI] [PubMed] [Google Scholar]
  5. DALES S., SIMINOVITCH L. The development of vaccinia virus in Earle's L strain cells as examined by electron microscopy. J Biophys Biochem Cytol. 1961 Aug;10:475–503. doi: 10.1083/jcb.10.4.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DALES S. The uptake and development of vaccinia virus in strain L cells followed with labeled viral deoxyribonucleic acid. J Cell Biol. 1963 Jul;18:51–72. doi: 10.1083/jcb.18.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Doms R. W., Blumenthal R., Moss B. Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane. J Virol. 1990 Oct;64(10):4884–4892. doi: 10.1128/jvi.64.10.4884-4892.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Easterbrook K. B. Controlled degradation of vaccinia virions in vitro: an electron microscopic study. J Ultrastruct Res. 1966 Mar;14(5):484–496. doi: 10.1016/s0022-5320(66)80077-1. [DOI] [PubMed] [Google Scholar]
  9. Grimley P. M., Rosenblum E. N., Mims S. J., Moss B. Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes. J Virol. 1970 Oct;6(4):519–533. doi: 10.1128/jvi.6.4.519-533.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hiller G., Weber K. Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment. J Virol. 1985 Sep;55(3):651–659. doi: 10.1128/jvi.55.3.651-659.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Holowczak J. A. Uncoating of poxviruses. I. Detection and characterization of subviral particles in the uncoating process. Virology. 1972 Oct;50(1):216–232. doi: 10.1016/0042-6822(72)90362-5. [DOI] [PubMed] [Google Scholar]
  12. Ichihashi Y., Oie M., Tsuruhara T. Location of DNA-binding proteins and disulfide-linked proteins in vaccinia virus structural elements. J Virol. 1984 Jun;50(3):929–938. doi: 10.1128/jvi.50.3.929-938.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ichihashi Y., Tsuruhara T., Oie M. The effect of proteolytic enzymes on the infectivity of vaccinia virus. Virology. 1982 Oct 30;122(2):279–289. doi: 10.1016/0042-6822(82)90227-6. [DOI] [PubMed] [Google Scholar]
  14. JOKLIK W. K., BECKER Y. THE REPLICATION AND COATING OF VACCINIA DNA. J Mol Biol. 1964 Dec;10:452–474. doi: 10.1016/s0022-2836(64)80066-8. [DOI] [PubMed] [Google Scholar]
  15. Joklik W. K. The poxviruses. Bacteriol Rev. 1966 Mar;30(1):33–66. doi: 10.1128/br.30.1.33-66.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kane E. M., Shuman S. Vaccinia virus morphogenesis is blocked by a temperature-sensitive mutation in the I7 gene that encodes a virion component. J Virol. 1993 May;67(5):2689–2698. doi: 10.1128/jvi.67.5.2689-2698.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Krijnse-Locker J., Ericsson M., Rottier P. J., Griffiths G. Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step. J Cell Biol. 1994 Jan;124(1-2):55–70. doi: 10.1083/jcb.124.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Locker J. K., Rose J. K., Horzinek M. C., Rottier P. J. Membrane assembly of the triple-spanning coronavirus M protein. Individual transmembrane domains show preferred orientation. J Biol Chem. 1992 Oct 25;267(30):21911–21918. doi: 10.1016/S0021-9258(19)36699-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Morgan C. The insertion of DNA into vaccinia virus. Science. 1976 Aug 13;193(4253):591–592. doi: 10.1126/science.959819. [DOI] [PubMed] [Google Scholar]
  20. Moss B., Rosenblum E. N., Katz E., Grimley P. M. Rifampicin: a specific inhibitor of vaccinia virus assembly. Nature. 1969 Dec 27;224(5226):1280–1284. doi: 10.1038/2241280a0. [DOI] [PubMed] [Google Scholar]
  21. Moss B., Rosenblum E. N. Letter: Protein cleavage and poxvirus morphogenesis: tryptic peptide analysis of core precursors accumulated by blocking assembly with rifampicin. J Mol Biol. 1973 Dec 5;81(2):267–269. doi: 10.1016/0022-2836(73)90195-2. [DOI] [PubMed] [Google Scholar]
  22. Niles E. G., Seto J. Vaccinia virus gene D8 encodes a virion transmembrane protein. J Virol. 1988 Oct;62(10):3772–3778. doi: 10.1128/jvi.62.10.3772-3778.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Payne L. Polypeptide composition of extracellular enveloped vaccinia virus. J Virol. 1978 Jul;27(1):28–37. doi: 10.1128/jvi.27.1.28-37.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rodriguez D., Rodriguez J. R., Esteban M. The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene. J Virol. 1993 Jun;67(6):3435–3440. doi: 10.1128/jvi.67.6.3435-3440.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rodriguez J. F., Janeczko R., Esteban M. Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus. J Virol. 1985 Nov;56(2):482–488. doi: 10.1128/jvi.56.2.482-488.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Rodriguez J. F., Paez E., Esteban M. A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. J Virol. 1987 Feb;61(2):395–404. doi: 10.1128/jvi.61.2.395-404.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rodriguez J. F., Smith G. L. IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. Nucleic Acids Res. 1990 Sep 25;18(18):5347–5351. doi: 10.1093/nar/18.18.5347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rodriguez J. R., Rodriguez D., Esteban M. Insertional inactivation of the vaccinia virus 32-kilodalton gene is associated with attenuation in mice and reduction of viral gene expression in polarized epithelial cells. J Virol. 1992 Jan;66(1):183–189. doi: 10.1128/jvi.66.1.183-189.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rosel J., Moss B. Transcriptional and translational mapping and nucleotide sequence analysis of a vaccinia virus gene encoding the precursor of the major core polypeptide 4b. J Virol. 1985 Dec;56(3):830–838. doi: 10.1128/jvi.56.3.830-838.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sarov I., Joklik W. K. Characterization of intermediates in the uncoating of vaccinia virus DNA. Virology. 1972 Nov;50(2):593–602. doi: 10.1016/0042-6822(72)90410-2. [DOI] [PubMed] [Google Scholar]
  31. Sarov I., Joklik W. K. Isolation and characterization of intermediates in vaccinia virus morphogenesis. Virology. 1973 Mar;52(1):223–233. doi: 10.1016/0042-6822(73)90411-x. [DOI] [PubMed] [Google Scholar]
  32. Sarov I., Joklik W. K. Studies on the nature and location of the capsid polypeptides of vaccinia virions. Virology. 1972 Nov;50(2):579–592. doi: 10.1016/0042-6822(72)90409-6. [DOI] [PubMed] [Google Scholar]
  33. Schmelz M., Sodeik B., Ericsson M., Wolffe E. J., Shida H., Hiller G., Griffiths G. Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol. 1994 Jan;68(1):130–147. doi: 10.1128/jvi.68.1.130-147.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Silver M., Dales S. Biogenesis of vaccina: interrelationship between post-translational cleavage, virus assembly, and maturation. Virology. 1982 Mar;117(2):341–356. doi: 10.1016/0042-6822(82)90474-3. [DOI] [PubMed] [Google Scholar]
  35. Sodeik B., Cudmore S., Ericsson M., Esteban M., Niles E. G., Griffiths G. Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus. J Virol. 1995 Jun;69(6):3560–3574. doi: 10.1128/jvi.69.6.3560-3574.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sodeik B., Doms R. W., Ericsson M., Hiller G., Machamer C. E., van 't Hof W., van Meer G., Moss B., Griffiths G. Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks. J Cell Biol. 1993 May;121(3):521–541. doi: 10.1083/jcb.121.3.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sodeik B., Griffiths G., Ericsson M., Moss B., Doms R. W. Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65. J Virol. 1994 Feb;68(2):1103–1114. doi: 10.1128/jvi.68.2.1103-1114.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Tartaglia J., Piccini A., Paoletti E. Vaccinia virus rifampicin-resistance locus specifies a late 63,000 Da gene product. Virology. 1986 Apr 15;150(1):45–54. doi: 10.1016/0042-6822(86)90264-3. [DOI] [PubMed] [Google Scholar]
  39. Van Meir E., Wittek R. Fine structure of the vaccinia virus gene encoding the precursor of the major core protein 4 a. Arch Virol. 1988;102(1-2):19–27. doi: 10.1007/BF01315559. [DOI] [PubMed] [Google Scholar]
  40. VanSlyke J. K., Franke C. A., Hruby D. E. Proteolytic maturation of vaccinia virus core proteins: identification of a conserved motif at the N termini of the 4b and 25K virion proteins. J Gen Virol. 1991 Feb;72(Pt 2):411–416. doi: 10.1099/0022-1317-72-2-411. [DOI] [PubMed] [Google Scholar]
  41. Vanslyke J. K., Hruby D. E. Immunolocalization of vaccinia virus structural proteins during virion formation. Virology. 1994 Feb;198(2):624–635. doi: 10.1006/viro.1994.1074. [DOI] [PubMed] [Google Scholar]
  42. Vanslyke J. K., Whitehead S. S., Wilson E. M., Hruby D. E. The multistep proteolytic maturation pathway utilized by vaccinia virus P4a protein: a degenerate conserved cleavage motif within core proteins. Virology. 1991 Aug;183(2):467–478. doi: 10.1016/0042-6822(91)90976-i. [DOI] [PubMed] [Google Scholar]
  43. Weir J. P., Moss B. Use of a bacterial expression vector to identify the gene encoding a major core protein of vaccinia virus. J Virol. 1985 Nov;56(2):534–540. doi: 10.1128/jvi.56.2.534-540.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Yang W. P., Bauer W. R. Purification and characterization of vaccinia virus structural protein VP8. Virology. 1988 Dec;167(2):578–584. [PubMed] [Google Scholar]
  45. Yang W. P., Kao S. Y., Bauer W. R. Biosynthesis and post-translational cleavage of vaccinia virus structural protein VP8. Virology. 1988 Dec;167(2):585–590. [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES